Park Medi World peers

·Pharma & HealthChart ›

Companies like Park Medi Worldlatest year

Park Medi WorldPARKHOSPS · FY26 · this company
Market cap₹9,556
P/E32.21×
Sales growth—
ROE12.8%
Max Healthcare InstituteMAXHEALTH · FY26
Open ›
Market cap₹82,828
P/E57.39×
Sales growth+20.3%
ROE14.3%
Fortis HealthcareFORTIS · FY26
Open ›
Market cap₹56,992
P/E54.70×
Sales growth+17.5%
ROE11.1%
Global HealthMEDANTA · FY26
Open ›
Market cap₹34,922
P/E62.76×
Sales growth+26.5%
ROE15.2%

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

PARKHOSPS₹221.25

Park Medi World Ltd.

· Pharma & Health
₹ CrorePeersMAXHEALTHFORTISMEDANTAMETROPOLISMARKSANSRUBICONJLHLSHILPAMEDMcap ₹9,556 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
PARKHOSPS
FY26
MAXHEALTH
FY26
FORTIS
FY26
MEDANTA
FY26
Peer
Average
Valuation — at last close
P/E◆ 32.21×57.39×54.70×62.76×58.28× -45%
P/B◆ 4.73×7.71×5.76×8.82×7.43× -36%
EV/EBITDA◆ 21.24×38.17×28.57×38.09×34.94× -39%
Market Cap₹9,556 Cr₹82,828 Cr₹56,992 Cr₹34,922 Cr₹58,247 Cr -84%
Growth
Revenue CAGR 3Y—◆ 22.43%13.17%17.85%17.82%
Revenue CAGR 5Y—◆ 27.30%17.76%—22.53%
Net Income CAGR 3Y—9.34%18.91%◆ 19.33%15.86%
Revenue YoY (latest Q)—20.31%17.46%◆ 26.50%21.42%
Net Income YoY (latest Q)—-15.64%◆ 2.26%-1.09%-4.82%
Profitability
EBITDA Margin26.46%◆ 26.79%22.84%20.84%23.49% +13%
Net Income Margin16.29%◆ 17.23%11.66%12.56%13.82% +18%
Return on Common Equity12.77%14.33%11.08%◆ 15.15%13.52% -6%
Return on Capital Employed◆ 16.72%12.63%12.62%14.78%13.34% +25%
Return on Assets9.72%8.89%7.18%◆ 10.38%8.82% +10%
Credit & Quality
Total Debt/Equity◆ 0.11×0.32×0.28×0.30×0.30× -63%
Interest Coverage6.48×7.64×5.20×◆ 8.80×7.21× -10%
Scale — latest FY
Revenue / Total Income₹1,679 Cr₹8,373 Cr₹9,128 Cr₹4,410 Cr₹7,304 Cr -77%
Net Income₹274 Cr₹1,442 Cr₹1,064 Cr₹554 Cr₹1,020 Cr -73%
Total Assets₹2,813 Cr₹17,231 Cr₹15,966 Cr₹5,905 Cr₹13,034 Cr -78%
EPS₹6.87₹14.83₹13.8₹20.71₹16.45 -58%
Book Value per Share₹46.81₹110.43₹131.07₹147.44₹129.65 -64%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.